Anat Shavit


Contact Details

T +972.3.694.4203
F +972.3.606.9609

vCardLinkedinDownload as PDF
“The ‘highly knowledgeable’ Anat Shavit attracts widespread praise from clients, who value her 'very strong technical skill and very good reputation'" Chambers & Partners "Impresses market sources with her 'good tactical skills" Chambers & Partners "Personal attention and dedication" Chambers & Partners

Ms. Shavit is the head of FBC's Tax Department and is recognized by international and domestic indices as one of Israel's leading tax practitioners.

Her diverse practice encompasses income tax, VAT, real estate tax, international tax matters, taxation of provident funds, tax implications of employee benefit plans, and compensation packages. Ms. Shavit also has considerable experience working with governmental and regulatory agencies involved in privatizations and restructurings.

Ms. Shavit has broad experience in handling complex M&A, financing, and capital markets transactions, and in the representation of venture capital and private equity funds in fund formation matters, as well as regarding investments in portfolio companies. 

Ms. Shavit’s on-going work for Israeli and multinational clients includes advising on cross-border tax structuring, representation before the Israeli tax authorities in ruling requests and settlement agreements, and providing opinions on tax-related issues.

Ms. Shavit is Co-Chair of the Tax Committee of the Central District of the Israel Bar Association.




Israel, 1996

Tel Aviv University, LL.B., 1994

Tel Aviv University, B.A. (Economics), 1994

Representation of Frutarom Industries Ltd. in its Acquisition of Enzymotec Ltd.

FBC represented Frutarom Industries Ltd. in its acquisition of Enzymotec Ltd. (NASD: ENZY), for approximately $210 million, at an equity value of approximately $290 million. Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Prior t...

Avraham Well & Sharon Rosen & Anat Shavit & Zohar Liss & Ziv Schwartz & Moran Friedman & Hilla Sachs | Jan 2018

FBC represented Perrigo in the sale of its active pharmaceutical ingredients business

FBC, in collaboration with US firm Morgan, Lewis & Bockius, represented Perrigo Company in the sale of its active pharmaceutical ingredients business headquartered in Israel for a purchase price of US$110 million. The transaction included the sale of all of the shar...

Raz Tepper & Sharon Klein-Manbar & Anat Shavit & Shay Teken & Talia Shekel & Idan Lange & Moran Friedman & Hilla Sachs & Tal Wiesengrun & Boaz Tavor | Aug 2017
Related News & Publications >>